Wealthfront Advisers LLC Biogen Inc. Transaction History
Wealthfront Advisers LLC
- $34 Billion
- Q4 2024
A detailed history of Wealthfront Advisers LLC transactions in Biogen Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 1,836 shares of BIIB stock, worth $218,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,836
Previous 53,858
96.59%
Holding current value
$218,961
Previous $8.24 Million
96.6%
% of portfolio
0.0%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding BIIB
# of Institutions
1,012Shares Held
126MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$1.91 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.73 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$882 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$441 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $17.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...